Published in Women's Health Weekly, March 29th, 2001
"Tamoxifen is a nonsteroidal anti-estrogenic drug used for adjuvant treatment of breast cancer and recently as a chemo-preventative agent for breast cancer and, on an investigational basis, for other cancers," reported J.G. Kral and colleagues from the Southern University of New York.
The researchers noted that case reports of hypertriglyceridemia and fatty liver disease have been demonstrated in tamoxifen users.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.